Considering that elevation Lp‐PLA2 contributes about 2‐fold risk for strokes or coronary artery disease, testing for Lp‐PLA2 might be a supplementary evaluation tool to classical cardiovascular risk assessment. The gene discussed is PLA2G7; the disease is Stroke.